GlaxoSmithKline Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2275.95

-50.35 (-2.16%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2275.95

-50.35 (-2.16%)
16:02 Dec 20

Quality

66/100
High Financial Strength

Valuation

14/100
Expensive Valuation

Technical

48/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	2925.6	3278.03	3251.72	3453.71	3560.48
Operating Expenses +	2327.47	2516.14	2447.44	2545.02	2532.91
Raw Material	1294.87	1340.62	1215.92	1398.25	1390.48
Increase Decrease in Cost	-38.02	15.57	68.96	-63.72	-26.75
Other Manufacturing Expense	0	0	73.85	0	0
Employee Cost	616.16	610.23	594.99	624.39	616.17
Miscellaneous Expenses	2100.64	2008.6	2070.58	2292.26	553.01
Operating Profit	598.13	761.89	804.28	908.69	1027.57
Other Income	110.58	75.78	100.66	122.59	128.12
Depreciation	78.6	68.19	65.77	69.68	68.48
Interest	3.53	2	1.81	1.8	1.73
Profit before tax and exceptio..	626.59	767.47	837.37	959.8	1085.48
Exceptional Items	-172.6	11.58	-0.97	-143.62	-156.22
PBT	453.99	779.05	836.4	816.19	1241.7
Provision for Taxation	166.72	398.28	228.76	226.23	254.23
Net Profit	358.15	1694.72	610.69	589.96	675.03
NET Profit after MI	358.15	1694.72	616.72	594.13	675.03
EPS	21.14	100.04	36.05	41.14	46.93
Operating Profit Margin (%)	20.44	23.24	24.73	26.31	28.86
Net Profit Margin (%)	12.24	51.7	18.97	17.2	18.96

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	75.00	75.00	75.00	75.00	75.00
FII	4.40	4.00	3.50	2.90	2.50
MF	5.00	4.70	4.50	4.50	4.80
Public	13.30	13.50	13.60	13.40	12.50
Others	0.00	0.00	0.00	0.00	0.00
Others	2.30	2.80	3.40	4.20	5.20